RT info:eu-repo/semantics/article
T1 MicroRNA-630: A promising avenue for alleviating inflammation in diabetic kidney disease
A1 Hernández Fernaud, Juan Ramón
A1 Donate Correa, Javier
A1 González Luis, Ainhoa
A1 Díaz Vera, Jésica
A2 BioquímicaMicrobiología, Biología Celular y Genética
A2 Área de microbiología. Universidad de La Laguna
AB Diabetic kidney disease (DKD) is one of the complications of diabetes, affecting millions of people worldwide. The relentless progression of this condition can lead to kidney failure, requiring life-altering interventions such as dialysis or transplants. Accumulating evidence suggests that immunologic and inflammatory elements play an important role in initiating and perpetuating the damage inflicted on renal tissues, exacerbating the decline in organ function. Toll-like receptors (TLRs) are a family of receptors that play a role in the activation of the innate immune system by the recognition of pathogen-associated molecular patterns. Recent data from in vitro and in vivo studies have highlighted the critical role of TLRs, mainly TLR2 and TLR4, in the pathogenesis of DKD. In the diabetic milieu, these TLRs recognize diabetic-associated molecular signals, triggering a proinflammatory cascade that initiates and perpetuates inflammation and fibrogenesis in the diabetic kidney. Emerging non-traditional strategies targeting TLR signaling with potential therapeutic implications in DKD have been proposed. One of these approaches is the use of microRNAs, small non-coding RNAs that can regulate gene expression. This editorial comments on the results of this approach carried out in a rat model of diabetes by Wu et al, published in this issue of the World Journal of Diabetes. The results of the experimental study by Wu et al shows that microRNA-630 decreased levels compared to non-diabetic rats. Additionally, microRNA-630 exerted anti-inflammatory effects in the kidneys of diabetic rats through the modulation of TLR4. These findings indicate that the microRNA-630/TLR4 axis might represent a pathological mechanism of DKD and a potential therapeutic target capable of curbing the destructive inflammation characteristic of DKD
YR 2024
FD 2024
LK http://riull.ull.es/xmlui/handle/915/38855
UL http://riull.ull.es/xmlui/handle/915/38855
LA en
DS Repositorio institucional de la Universidad de La Laguna
RD 19-oct-2024